Physiologic role and clinical significance of reverse cholesterol transport.
Low levels of high-density lipoproteins have been consistently shown to be a major risk factor for coronary heart disease. However, the precise role of HDL in the prevention or reversal of atherosclerosis (or both) is unknown. It has been proposed that HDL functions jointly with the enzyme lecithin:cholesterol acyltransferase and the cholesteryl ester transfer protein to facilitate the movement of cholesterol from tissues to the liver. This mechanism--referred to as reverse cholesterol transport--has been shown to be an important physiologic mechanism. However, its clinical significance, though intriguing, is unclear. This article reviews recent advances concerning the components of reverse cholesterol transport and evaluates their potential significance in the early diagnosis and treatment of atherosclerosis.
Bleicher
J M
JM
Department of Medicine, Texas College of Osteopathic Medicine, Fort Worth 76107-2690.
Lacko
A G
AG
D001161:Arteriosclerosis / Q000188:drug therapy / Q000378:metabolism / Q000517:prevention & control; D001693:Biological Transport, Active; D002352:Carrier Proteins / Q000502:physiology*; D002784:Cholesterol / Q000378:metabolism / Q000493:pharmacokinetics*; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL / Q000502:physiology*; D006023:Glycoproteins; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000502:physiology; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000502:physiology*; D014018:Tissue Distribution / Q000187:drug effects / Q000502:physiology
C506642:CETP protein, human; D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D006023:Glycoproteins; D002784:Cholesterol; D007862:Phosphatidylcholine-Sterol O-Acyltransferase